Jürgen Wolf

Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations

David M. Hyman, Igor Puzanov, Vivek Subbiah et al. · New England Journal of Medicine · 2015 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +12

<i>MET</i> Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

Hans‐Ulrich Schildhaus, Anne M. Schultheis, Josef Rüschoff et al. · Clinical Cancer Research · 2014 · 189 citations

Medicine, Genetics, Oncology +17

Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial

Jürgen Wolf, Maximilian J. Hochmair, Ji‐Youn Han et al. · The Lancet Oncology · 2024 · 64 citations · Full text

Medicine, Oncology, Pharmacology +12

HMGI-C, a Member of the High Mobility Group Family of Proteins, is Expressed in Hematopoietic Stem Cells and in Leukemic Cells

Birgit Rommel, Piere Rogalla, Andrea Jox et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1997 · 57 citations

Life Sciences, Genetics, Molecular Biology +16

Clinical Efficacy, Tolerability, and Safety of SAM486A, a Novel Polyamine Biosynthesis Inhibitor, in Patients with Relapsed or Refractory Non-Hodgkin’s Lymphoma

Miklos Pless, Karim Belhadj, Hans D. Menssen et al. · Clinical Cancer Research · 2004 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +13